Figure 2
The different localisation of activated c-Src, SrcpY416 in prostate and breast tumour samples are shown. In breast tumours, activated c-Src was most commonly present in the cell cytoplasm and the cell nucleus (A and B). In the prostate cancer (C and D), the majority of staining observed for phosphorylated c-Src was located to the membrane, and nuclear expression was rarely observed.
